Skip to main content
STRIDES PHARMA SCIENCE LIMITED logo

STRIDES PHARMA SCIENCE LIMITED — Investor Relations & Filings

Ticker · STAR ISIN · INE939A01011 LEI · 335800WHFYXUCHR9DD10 BSE.NS Manufacturing
Open in API
Filings indexed 1,200 across all filing types
Latest filing 2026-05-28 Regulatory Filings
Country IN India
Listing BSE.NS STAR

About STRIDES PHARMA SCIENCE LIMITED

https://www.strides.com

Strides Pharma Science Limited is a global pharmaceutical organization focused on the development and manufacture of IP-led niche finished dosage formulations. The company’s product portfolio encompasses a wide range of therapeutic areas, specializing in complex oral solids, softgel capsules, topicals, and liquids. It maintains a significant presence in highly regulated markets, including the United States, Europe, and Australia, while also serving institutional and emerging markets. The company operates multiple manufacturing facilities globally, many of which are approved by major international regulatory agencies such as the USFDA. Strides emphasizes research and development to drive innovation in specialized delivery systems and difficult-to-manufacture products, positioning itself as a key player in the global generic pharmaceutical landscape.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 81% confidence The document is an intimation under SEBI Listing Regulations to the stock exchanges regarding the schedule of Analyst/Institutional Investor non-deal roadshows. It merely notifies the exchange and public of upcoming investor meetings. It does not contain financial statements, the actual presentation materials, or constitute a report itself. It is a regulatory disclosure under listing rules, fitting the “Regulatory Filings” fallback category (RNS).
2026-05-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 85% confidence The document is a stock exchange disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) regarding the schedule of Analyst/Institutional Investor meetings. It does not contain financial results or detailed presentations itself, nor is it a request for votes, proxy materials, or an actual investor presentation. It is a compliance announcement informing the exchanges of an upcoming event and therefore falls under general regulatory filings.
2026-05-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 87% confidence The document is a SEBI Listing Obligation (Regulation 30) intimation to stock exchanges describing the schedule of analyst/institutional investor meetings. It does not contain financial statements or the report itself, but is a regulatory announcement of an upcoming investor road show. This falls under general regulatory filings (RNS) as a fallback category for miscellaneous compliance disclosures.
2026-05-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 85% confidence The document is an intimation under Regulation 30 of SEBI LODR notifying the stock exchanges of the schedule of analyst/institutional investor meetings (non-deal roadshows). It does not contain any financial statements or presentation itself and is a routine regulatory announcement. Therefore, it best fits the regulatory filings category (RNS).
2026-05-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 90% confidence The document is an exchange intimation under SEBI Listing Regulations (Regulation 30) notifying the schedule of an analyst/institutional investor meeting. It does not contain financial results or detailed presentation content itself, nor is it a formal report publication. It is a general regulatory announcement to stock exchanges, therefore it falls into the fallback category “Regulatory Filings (RNS)”.
2026-05-28 English
Schedule of Analyst/ Institutional Investor''s Meeting - as enclosed.
Regulatory Filings Classification · 90% confidence The document is a Reg. 30 intimation under SEBI LODR listing requirements, providing a schedule of non-deal roadshows/analyst meetings. It does not contain actual financial statements or a presentation itself but is an announcement of an upcoming investor event. This does not fit any specific category like an earnings release, investor presentation, or management discussion, so it defaults to a general regulatory announcement. Therefore, it should be classified as Regulatory Filings (RNS).
2026-05-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.